insulin aspart protamine and insulin aspart
| Brand name | Novolog Mix 70/30 |
|---|---|
| Active ingredient | insulin aspart protamine and insulin aspart |
| Strength | 210UNITS/3ML (70UNITS/ML); 90UNITS/3ML (30UNITS/ML) |
| Dosage form | Injectable Suspension |
| Route | Subcutaneous |
| Modality | Biologic |
| FDA approval | May 2002 |
| Marketing status | Rx |
Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.